Catholic University Industry Academic Cooperation Foundation;Hanlim Pharmaceutical Co., Ltd.
发明人:
申请号:
EP11750939.8
公开号:
EP2543374A2
申请日:
2011.03.04
申请国别(地区):
EP
年份:
2013
代理人:
摘要:
The present invention provides a pharmaceutical composition for preventing or treating osteoarthritis comprising rebamipide as an active ingredient and a pharmaceutically acceptable carrier. The pharmaceutical composition may be for oral administration, for example an oral solid dosage form of a tablet or capsule form. The pharmaceutical composition may be formulated into a unit dosage form suitable for orally administering rebamipide in a dose ranging from 0.5 to 50 mg/kg, preferably from 0.6 to 6 mg/kg.